95,563 Oscar Health, Inc. $OSCR Shares Sold by Corient Private Wealth LP

Key Points

• Corient Private Wealth LP cut its Oscar Health stake by 83.7% in the second quarter, selling 95,563 shares and retaining 18,589 shares worth approximately $530,000. Institutional investors collectively own 75.7% of the company.
• Analysts remain mixed on Oscar Health, with a consensus “Hold” rating and an average price target of $33.90; individual targets range from $30 to $48.
• Oscar Health reported strong quarterly results, posting $1.10 in EPS versus a $0.40 estimate and $4.88 billion in revenue, up 70.4% year over year. Shares recently traded near $30.86, compared with a 12-month range of $10.69 to $34.48.

Corient Private Wealth LP lowered its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 83.7% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 18,589 shares of the company's stock after selling 95,563 shares during the quarter. Corient Private Wealth LP's holdings in Oscar Health were worth $530,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the business. Comprehensive Financial Planning Inc. PA acquired a new position in shares of Oscar Health during the second quarter valued at about $309,000. AXQ Capital LP bought a new position in Oscar Health during the second quarter valued at about $1,059,000. Nykredit A S bought a new position in Oscar Health during the second quarter valued at about $130,000. Wellington Management Group LLP increased its stake in Oscar Health by 65.6% during the second quarter. Wellington Management Group LLP now owns 603,675 shares of the company's stock valued at $17,217,000 after acquiring an additional 239,109 shares during the period. Finally, Public Employees Retirement System of Ohio acquired a new position in Oscar Health in the 2nd quarter valued at approximately $154,000. 75.70% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on OSCR. Stephens reiterated an "equal weight" rating and issued a $34.00 price objective on shares of Oscar Health in a research report on Thursday, September 17th. Weiss Ratings upgraded Oscar Health from a "sell (d+)" rating to a "hold (c+)" rating in a research report on Tuesday, August 11th. Bank of America upped their target price on Oscar Health from $28.00 to $30.00 and gave the company an "underperform" rating in a research note on Thursday, September 17th. Wall Street Zen raised Oscar Health from a "buy" rating to a "strong-buy" rating in a research report on Sunday, June 14th. Finally, Piper Sandler reiterated an "overweight" rating and set a $48.00 price target on shares of Oscar Health in a research note on Thursday, September 17th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Oscar Health has an average rating of "Hold" and a consensus target price of $33.90.

Insiders Place Their Bets

In related news, Director Mario Schlosser sold 31,422 shares of the business's stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $988,221.90. Following the completion of the transaction, the director owned 449,444 shares in the company, valued at $14,135,013.80. The trade was a 6.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Victoria Baltrus sold 958 shares of the business's stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $31.45, for a total transaction of $30,129.10. Following the completion of the transaction, the chief accounting officer owned 213,631 shares of the company's stock, valued at $6,718,694.95. This trade represents a 0.45% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 874,451 shares of company stock valued at $26,761,671 over the last quarter. Company insiders own 22.64% of the company's stock.

Oscar Health Stock Performance

Shares of NYSE:OSCR opened at $30.86 on Thursday. Oscar Health, Inc. has a twelve month low of $10.69 and a twelve month high of $34.48. The firm has a market cap of $9.52 billion, a PE ratio of 22.04, a price-to-earnings-growth ratio of 0.33 and a beta of 2.37. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The business has a fifty day moving average of $30.76 and a 200-day moving average of $25.01.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.70. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The firm's quarterly revenue was up 70.4% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.89) EPS. On average, equities research analysts predict that Oscar Health, Inc. will post 1.83 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc is a technology-driven health insurance company that provides health plans and related services to individuals, families and businesses in the United States. The company primarily serves members through plans offered under the Affordable Care Act (ACA), including individual and family coverage purchased through government marketplaces.

Oscar's offerings include medical insurance plans with access to provider networks, prescription drug coverage and member support services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.